Great Lakes Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118M Sell
543,816
-51,812
-9% -$11.5M 0.98% 33
2025
Q4
$136M Sell
595,628
-8,781
-1% -$2M 1.11% 22
2025
Q3
$140M Sell
604,409
-6,773
-1% -$1.38M 1.17% 18
2025
Q2
$113M Sell
611,182
-239,493
-28% -$44.5M 0.95% 22
2025
Q1
$178M Sell
850,675
-21,384
-2% -$4.16M 1.59% 4
2024
Q4
$155M Buy
872,059
+9,957
+1% +$1.83M 1.33% 11
2024
Q3
$170M Sell
862,102
-2,108
-0.2% -$393K 1.43% 6
2024
Q2
$148M Buy
864,210
+143,263
+20% +$23.7M 1.32% 9
2024
Q1
$131M Buy
720,947
+23,744
+3% +$4.09M 1.11% 18
2023
Q4
$108M Sell
697,203
-179,891
-21% -$26.2M 1.03% 24
2023
Q3
$131M Buy
877,094
+182,823
+26% +$26.8M 1.19% 14
2023
Q2
$93.5M Sell
694,271
-156,499
-18% -$22.9M 0.93% 26
2023
Q1
$136M Buy
850,770
+433,447
+104% +$66.3M 1.23% 11
2022
Q4
$7.93M Buy
417,323
+9,370
+2% +$1.44M 0.45% 47
2022
Q3
$54.8M Sell
407,953
-29,728
-7% -$4.27M 1.2% 14
2022
Q2
$67M Sell
437,681
-123,749
-22% -$18.9M 1.33% 11
2022
Q1
$91M Buy
561,430
+98,413
+21% +$14.3M 1.49% 4
2021
Q4
$62.7M Buy
463,017
+8,381
+2% +$990K 0.95% 16
2021
Q3
$49M Buy
454,636
+1,911
+0.4% +$218K 0.76% 31
2021
Q2
$51M Buy
452,725
+24,106
+6% +$2.71M 0.77% 31
2021
Q1
$46.4M Sell
428,619
-2,041
-0.5% -$218K 0.75% 31
2020
Q4
$46.1M Buy
430,660
+3,461
+0.8% +$333K 0.84% 29
2020
Q3
$37.4M Buy
427,199
+769
+0.2% +$72.4K 0.79% 33
2020
Q2
$41.9M Sell
426,430
-174,403
-29% -$15.4M 1.02% 21
2020
Q1
$45.8M Sell
600,833
-53,741
-8% -$4.58M 1.34% 9
2019
Q4
$58M Sell
654,574
-47,988
-7% -$3.98M 1.24% 12
2019
Q3
$53.2M Sell
702,562
-2,589
-0.4% -$178K 1.17% 20
2019
Q2
$51.3M Buy
705,151
+86,460
+14% +$6.8M 1.12% 28
2019
Q1
$49.9M Sell
618,691
-9,342
-1% -$764K 1.11% 26
2018
Q4
$57.9M Sell
628,033
-19,751
-3% -$1.74M 1.37% 12
2018
Q3
$61.3M Buy
647,784
+45,742
+8% +$4.34M 1.35% 19
2018
Q2
$55.8M Sell
602,042
-75,515
-11% -$7.37M 1.31% 18
2018
Q1
$57.5M Buy
677,557
+229,535
+51% +$25.2M 1.37% 19
2017
Q4
$43.3M Sell
448,022
-10,505
-2% -$990K 0.95% 36
2017
Q3
$40.7M Sell
458,527
-202,142
-31% -$15.4M 0.96% 39
2017
Q2
$47.9M Sell
660,669
-225,782
-25% -$15.2M 1.18% 29
2017
Q1
$57.8M Sell
886,451
-27,189
-3% -$1.71M 1.49% 19
2016
Q4
$57.2M Buy
913,640
+197,302
+28% +$12M 1.5% 14
2016
Q3
$45.2M Sell
716,338
-36,484
-5% -$2.36M 1.23% 28
2016
Q2
$46.6M Buy
752,822
+72,416
+11% +$4.41M 1.27% 20
2016
Q1
$38.9M Buy
680,406
+76,058
+13% +$4.24M 1.06% 35
2015
Q4
$35.8M Sell
604,348
-43,953
-7% -$2.53M 1.07% 33
2015
Q3
$35.8M Buy
648,301
+52,623
+9% +$3.43M 1.11% 34
2015
Q2
$40M Buy
595,678
+69,941
+13% +$4.57M 1.22% 29
2015
Q1
$30.8M Buy
525,737
+181,998
+53% +$11M 0.94% 37
2014
Q4
$22.5M Buy
343,739
+541
+0.2% +$34.1K 0.7% 46
2014
Q3
$19.8M Sell
343,198
-17,620
-5% -$978K 0.66% 45
2014
Q2
$20.4M Buy
360,818
+12,327
+4% +$647K 0.84% 41
2014
Q1
$17.9M Sell
348,491
-3,286
-0.9% -$166K 0.78% 42
2013
Q4
$18.6M Sell
351,777
-132,425
-27% -$6.51M 0.84% 42
2013
Q3
$21.7M Sell
484,202
-20,994
-4% -$931K 0.97% 38
2013
Q2
$20.9M Buy
+505,196
New +$22.1M 0.98% 40

Other funds holding ABBV

Great Lakes Advisors's ABBV Position: Q1 2026 in Review

Great Lakes Advisors reduced its AbbVie (ABBV) stake by 8.7% in Q1 2026, selling an estimated $11.5M and leaving 543,816 shares worth $118M. The position accounts for 0.98% of the portfolio, ranked #33.

Great Lakes Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $178M in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Great Lakes Advisors held 543,816 shares of AbbVie worth $118M as of Q1 2026.
  • Great Lakes Advisors sold 51,812 AbbVie shares in Q1 2026, an estimated $11.5M.
  • AbbVie made up 0.98% of Great Lakes Advisors's portfolio in Q1 2026, its #33 holding.
  • Great Lakes Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Great Lakes Advisors's AbbVie position peaked at $178M in Q1 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Great Lakes Advisors's 13F filing for Q1 2026, filed 12 May 2026.